4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-014607
Co-Chief Executive Officer sold 11,855 shares at $3.47 ($41,104)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2025-02-03 | Sale | −11,855 | $3.47 | $41,104 | 3,164,933 | D |
| Open-market sales · 11,855 sh · avg $3.47 · $41,104 | |||||||
Loading xslF345X05/ownership.xml…